Special Report

OIG: Improved oversight of standalone compounding pharmacies needed

Compounding pharmacies providing medications to hospitals need better oversight, according to a new report from the Department of Health and Human Services' Office of Inspector General (OIG). The OIG decided to take a look at the issue after the 2012 nationwide meningitis outbreak was found to be caused by a standalone compounding pharmacy that produced contaminated steroids for injection.

RELATED COVERAGE

• DQSA: New regs give FDA broader powers over compounding

• New compounding regulations will greatly enhance safety: FDA

• FDA offers more guidance for "outsourcing facilities"

IN THIS ISSUE

• Drug Topics' 2015 Salary Survey

• ASHP Midyear: Ebola treatment in America

• ASHP Midyear: Streamline HCV care with specialty pharmacy

Editorial Questions? Contact the Editorial Team. Click Here.
Sales, Reprints, Classified questions? Contact the Sales Team. Click Here.